OMOlga Vladislavovna Mysnychenko

Olga Vladislavovna Mysnychenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olga Vladislavovna Mysnychenko has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Single-pill combination of perindopril, indapamide, and amlodipine in hypertensive patients with obesity: long-term efficacy

    by S. M. Koval, O. V. Mysnychenko, M. Y. Penkova, V. I. Pankiv, I. V. Chernyavska, O. M. Lytvynova, O. E. Berezin

    Treatment of patients with arterial hypertension associated with abdominal obesity (AO) is complex and most often requires the use of several antihypertensive agents. Achieving target of blood pressure (BP) is most difficult in cases of association of hypertension with a number of metabolic diseases, the most common of which is AO. When hypertension is combined with AO, there is a more rapid and pronounced development of such pathological changes as activation of the renin-angiotensin-aldosterone system, atherogenic dyslipidemia, insulin resistance, hypeuricemia and subclinical inflammation. Objective — to evaluate the advantages of the single-pill combination (SPC) of perindopril, indapamide and amlodipine in comparison with their free combination (FC) in achieving effective control of hypertension for a long time in patients with AO. Materials and methods. 75 patients (of which 45 men) with uncontrolled hypertension associated with AO (age 48 — 66 years old) were examined. Among patients included in the study, 36 received a FC of perindopril, indapamide and amlodipine, and 39 — SPC of these drugs. The drugs were used once a day in the following daily doses: perindopril — 4 — 8 mg, indapamide — 1.25 — 2.5 mg and amlodipine — 5 — 10 mg. Patients were followed up for 12 months. Results. SPC of perindopril, indapamide and amlodipine were significantly more effective than FC in hypertensive patients with АO. The high efficiency of SPC persisted for a long time (over the course of 12 months) and associated with significantly increased adherence to therapy in comparison with FC. To achieve target BP levels with SPC, lower doses of drugs were required than with FC. Conclusions. SPC of P, I and A shows greater efficiency than FC, and makes it possible to maintain BP within the target levels for a long time with lower doses of drugs. The high efficiency of SPC associated with significantly increased adherence to therapy in comparison with FC. To achieve target BP levels with SPC, lower doses of drugs were required than with FC. SPC and FC in patients with hypertension and AO contributed to the inhibition of asymptomatic hypertension-mediated organ damage progression, did not adversely affect metabolic parameters, and were characterized by high safety.

  • Open Access

    Cardiovascular diseases, their risk factors and adaptation disorders in a cohort of civilians who were in the combat zone during the war in the city of Kharkiv

    by S. M. Koval, L. A. Rieznik, T. G. Starchenko, O. V. Mysnychenko, M. Y. Penkova, A. V. Sharshava

    Objective — to study the frequency and severity of cardiovascular diseases (CVD), their risk factors, and adaptation disorders in a cohort of civilians who were in the combat zone during the war in the city of Kharkiv and were exposed to chronic wartime stress. Materials and methods. The study included 116 civilians living in the city of Kharkiv who were in the combat zone during the war and were exposed to chronic wartime stress. All surveyed civilians were employees of one of the Higher Education Institutions of Kharkiv. Among the surveyed were 67 men and 49 women aged 45 to 59 years (mean age — 51.4±4.3 years). All civilians underwent a screening general clinical laboratory and instrumental examination and psychological testing using a special questionnaire — the Hospital Anxiety and Depression Scale — HADS. The presence of CVD and their main risk factors was determined according to Ukrainian recommendations. Statistical analysis of the data obtained was carried out using standard methods using Microsoft Excel 7.0 and «SPSS 19.0». Results. It was found that the vast majority of civilians who were in the combat zone during the war and experienced chronic wartime stress (86.20%) were diagnosed with CVD and/or their main risk factors. The most common CVDs were: arterial hypertension (AH) (68.10%) and cardiac rhythm and conduction disorders that did not require cardiac surgery (56.03%). The frequency of ischemic heart disease (in 15.51% of people) and stage C heart failure, which was detected in 17.24% of people (with preserved ejection fraction — in 15.51% and with moderately reduced — in 1.72%), was significantly lower. The most common risk factors for CVD were: dyslipidemia (79.31%), low physical activity (56.90%), abdominal obesity (37.07%), and insulin resistance (31.03%). Low awareness of the surveyed about the presence of CVD (54.43%) and their risk factors (43.48%). The civilian cohort was characterized by a high frequency of adaptation disorders (anxiety disorders (56.90%) and depressive disorders (41.38%), which were associated with an increased frequency of hypertension, cardiac rhythm and conduction disorders, dyslipidemia, smoking, and insulin resistance. Conclusions. In a cohort of civilians who were in a combat zone during the war, a very high frequency of the main risk factors for CVD and already formed CVD and their reliable association with anxiety and depressive disorders were found. The need for a comprehensive examination of the specified contingent of civilians was proven in order to detect CVD and their risk factors as early as possible and to implement effective treatment and preventive measures in a timely manner.

  • Open Access

    Proinflammatory humoral factors and their role in the pathogenesis of left ventricular hypertrophy in hypertension (literature review)

    by Dmytro Myloslavskyi, Sergiy Koval, Olga Mysnychenko, Olga Lytvynova, Olena Shcheniavska

    The aim of the research was to consider the role of chronic low-grade systemic inflammation and a list of pro-inflammatory factors (interleukins, chemokines, tumor necrosis factor alpha, adipocytokines, metalloproteinases and their inhibitors, growth and inflammatory factors, etc.) as predictors of the onset and progression of left ventricular hypertrophy and myocardial fibrosis in individuals with hypertension Materials and Methods: keywords search of native and foreign sources of literature from scientometric databases Google Scholar, Clarivate, Web of Science, Scopus, PubMed and its analysis, considering data from modern European and Ukrainian guidelines of recent years was performed. Results and Discussion. Data on the conditional classification of pro-inflammatory and anti-inflammatory cytokines, their activity in hypertensive heart and diastolic dysfunction, a number of traditional pro-inflammatory factors from the superfamilies of interleukins, pentraxins and transforming growth factor beta 1 are considered, as well as new promising biomolecules that are used as indicators of chronic low-grade systemic inflammation, including the experiments on hypertensive animals. The question of the prospects of using a multi-indicator model of pro-inflammatory factors in individuals with arterial hypertension is considered, a brief description of promising targeted therapeutic approaches to inhibit pro-inflammatory mechanisms in patients with is given. Conclusions. In the research works of the last 10 years, a high scientific interest in the pathogenetically significant role of chronic low-grade systemic inflammation, pro-inflammatory factors in the occurrence and progression of hypertensive heart disease and left ventricular hypertrophy has revealed, and the promise of using biomarkers as their indicators for further personalized treatment on this basis for this category of patients has proven

  • Open Access

    Effectiveness and adherence to antihypertensive therapy in patients with hypertensive disease who were in the combat zone during the war

    by S.M. Koval, O.V. Mysnychenko, M.YU. Penkova, О.м. Lytvynova, V.YU. Kovalevska

    Background. One of the key factors leading to the development and progression of hypertensive disease (HD) is stress. The most powerful cause of stress is war. It has been shown that during wartime, many people develop a specific form — wartime hypertension. In addition to wartime hypertension, another consequence of chronic stress during wars and armed conflicts is the progression of pre-existing HD. The problems of effectiveness and adherence to treatment of patients with HD are very acute during wartime. However, the literature in this area is limited. Purpose: to study the effectiveness of antihypertensive therapy and adherence to it in patients with HD — civilians who were in a combat zone during the war. Materials and methods. Sixty-two patients (29 men, 33 women) aged 45 to 65 years (mean of 52.4 ± 4.3 years) with HD degree 2–3, representatives of the civilian population who were in the combat zone during the war, were examined. The interval between the examination before the war and after stay in the combat zone was 8–9 months. All patients underwent general clinical laboratory and instrumental examination. Statistical analysis of the data obtained was carried out using standard methods with the application packages Microsoft Excel 7.0 and SPSS 19.0. Results. The vast majority (77 %) of patients with HD who were in the combat zone during the war experienced a significant decrease in the effectiveness of individually selected antihypertensive therapy. It was manifested in a significantly reduced frequency of achieving target blood pressure levels, an increase in the severity of hypertension, in the frequency of hypertensive crises and resistant forms of the disease. A decreased effectiveness of antihypertensive therapy in the examined patients occurred against the background of a significant decrease in adherence to the prescribed therapy from 100 to 64 % (p < 0.05). However, non-adherence was the reason for a decrease in therapy effectiveness only in some patients (36 %). Very important reasons for a decrease in the effectiveness of antihypertensive therapy in patients with HD during the war are chronic wartime stress, which leads to the development of anxiety and depressive disorders, activation of prohypertensive factors, and progression of hypertension. Conclusions. The results of the study indicate the need for careful monitoring of the degree of hypertension control and adherence to antihypertensive therapy in order to ensure timely correction of these indicators, prevent the progression of hypertension and the development of its complications.


  • Open Access

    Effectiveness of a fixed combination of empagliflozin with metformin in reduction of cardiovascular risk in patients with uncontrolled arterial hypertension and decompensated type 2 diabetes mellitus

    by С. М. Коваль, L. A. Rieznik, O. V. Mysnychenko, М. Ю. Пенькова

    Objective is to study the effectiveness of a fixed combination of empagliflozin and metformin in reducing cardiovascular risk in patients with uncontrolled arterial hypertension (AH) and decompensated type 2 diabetes mellitus (DM). Materials and methods. 36 patients with uncontrolled AH and decompensated type 2 diabetes mellitus aged 45 to 60 were examined. Before inclusion in the study, all patients received standard antihypertensive (angiotensin‑converting enzyme (ACE) inhibitor or angiotensin‑II receptor blocker (ARB) in combination with a calcium channel blocker and a thiazide‑like diuretic), glucose‑lowering (metformin) and hypolipidemic (atorvastatin) therapy. However, target levels of blood pressure (BP), glycated haemoglobin (HbA1c) and lipids were not achieved. After the initial examination, all patients were prescribed a fixed combination of empagliflozin and metformin at a dose of 12.5 mg/1000 mg 1—2 times a day, and antihypertensive and hypolipidemic therapy was continued. Re‑examination was carried out after 20 weeks. In the work, a statistical analysis of the obtained data was carried out using standard methods using Microsoft Excel 7.0 and SPSS 19.0 application packages. Results. The transfer of the examined patients from previous ineffective hypoglycemic therapy to a fixed combination of empagliflozin with metformin against the background of standard antihypertensive and hypolipidemic therapy made it possible to achieve the target levels of HbA1c in 69% of patients and target BP levels in 64%. The frequency of reaching target BP levels in the subgroup of patients who received ARB was significantly higher than in the subgroup of patients who received ACE inhibitors. The specified therapy contributed to a significant reduction in body weight, reaching the target levels of low‑density lipoprotein cholesterol (LDL‑C) and non‑high‑density lipoprotein cholesterol (Non‑HDL‑C) in more than a third of patients, and reducing the severity of albuminuria in some patients. The tested therapy, in general, led to reduction in cardiovascular risk and did not cause side effects that could lead to discontinuation of treatment. Conclusions. The fixed combination of empagliflozin with metformin against the background of standard antihypertensive and hypolipidemic therapy in patients with uncontrolled hypertension and decompensated type 2 diabetes mellitus contributed to the achievement in the vast majority of patients of the target levels of HbA1c in the blood and BP levels, reduced body weight, positive changes in lipid metabolism and kidney function, and demonstrated the possibility of a significant reduction in cardiovascular risk. A more pronounced decrease in BP was detected in the case of a fixed combination of empagliflozin and metformin with ARB compared to ACE inhibitors in this category of patients.

  • Open Access

    Circulating microRNA-21-3p in patients with arterial hypertension

    by С. М. Коваль, I. O. Snihurska, O. V. Mysnychenko, М. Ю. Пенькова, V. Y. Galchiska, І. О. Снігурська, В. Ю. Гальчинська

    Objective — to study changes in the blood plasma levels of microRNA‑21‑3p in patients with arterial hypertension (AH) and their relationship with the characteristics of the course of the disease. Materials and methods. Examinations involved 24 patients with hypertension stage II and degree 2—3 (11 men, 13 women) aged from 42 to 60 years. The control group consisted of 12 practically healthy individuals, age and gender matching. The examinations were carried out in the Department of Hypertension and Kidney Diseases of the GI «L. T. Mala National Therapy Institute of NAMS of Ukraine». The degree, stage of hypertension and the presence of risk factors for cardiovascular diseases (CVD), established CVD and kidney disease were assessed in accordance with current recommendations. All patients underwent general clinical laboratory and instrumental examinations. The blood plasma level of circulating microRNA‑21‑3p was determined by quantitative reverse transcriptase‑polymerase chain reaction (qRT‑PCR) using reagent kits for monitoring and analyzing microRNA expression «TaqMan microRNA Assay» (ThermoFisher Scientific, USA). Small nuclear RNA U6 was used as a reference. Relative expression was calculated in relative units (r.u.) using the ΔΔCt method. Statistical analysis of the obtained data was carried out using standard methods with application packages Microsoft Excel and SPSS 19.0. Results. A significant decrease in the plasma levels of microRNA‑21‑3p in patients with hypertension was established in comparison with practically healthy individuals. The most pronounced decrease in plasma microRNA‑21‑3p levels was observed in patients with the most severe hypertension (stage 3 AH) and in subjects, in whom antihypertensive therapy did not result in the achieving target levels of «office» blood pressure (BP). Significant negative correlations were found between the plasma microRNA‑21‑3p levels and hemodynamic parameters (BP levels) and the left ventricular myocardial mass index — an indicator of the severity of left ventricular hypertrophy, one of the key lesions of target organs. The obtained results indicate the presence in patients with hypertension of a significant deficiency in the production of microRNA‑21‑3p, which, according to the literature data, has pronounced antihypertensive and cardiovascular‑ and renoprotective properties. Conclusions. A significant decrease in the blood plasma levels of microRNA‑21‑3p, the endogenous regulator of gene expression with antihypertensive and organoprotective properties, was established in patients with hypertension in comparison with practically healthy subjects. The revealed decrease in the blood plasma levels of this microRNA was enhanced at severe and uncontrolled hypertension and associated with the degree of hypertensive heart damage. The data obtained indicate the important role of microRNA‑21‑3p in the hypertension pathogenesis and the prospects of finding methods for correcting its production.

  • Open Access

    Changes in the nature of the disease in patients with hypertension and type 2 diabetes mellitus — representatives of the civilian population after a long stay in the combat zone

    by S.M. Koval, M.YU. Penkova, O.V. Mysnychenko

    Background. In modern conditions, an acute problem in medicine is the issue of a negative impact of war on the course of chronic noncommunicable diseases. The most common of them are hypertension and type 2 diabetes mellitus, which in most cases occur as a comorbidity. To date, a certain amount of work has been carried out to study the influence of war and chronic wartime stress on the development and progression of hypertension. However, the features of the course of hypertension and type 2 diabetes in case of their combination during a long-term stay of patients in combat zones remain unstudied. The purpose: to study changes in the nature of the disease course in patients with hypertension and type 2 diabetes — representatives of the civilian population after a long stay in the combat zone of the Kharkiv region of Ukraine. Materials and methods. Sixty-five patients (civilians) with hypertension and type 2 diabetes (30 men, 35 women) aged from 47 to 64 years were examined. All of them were examined before the start of the war and 4–5 months after staying in the combat zone. Results. In hypertensive patients with type 2 diabetes after their stay in a combat zone, hypertension became more severe (in 89 % of cases, it was uncontrolled, the frequency of hypertensive crisis and resistant hypertension increased significantly). In addition, a significant increase in the frequency of decompensation of carbohydrate metabolism was detected. The examined patients showed a progression of lipid metabolism disorders and the development of new cases of cardiovascular and cerebrovascular diseases. Conclusions. There was a pronounced negative impact of long-term stay of patients with hypertension and type 2 diabetes in a combat zone on the course of both hypertension and diabetes, which was associated with a significant increase in the incidence of cardiovascular and cerebrovascular diseases.


  • Open Access

    Arterial hypertension in military personnel and veterans of various wars. Literature review

    by С. М. Коваль, I. O. Snihurska, O. V. Mysnychenko, М. Ю. Пенькова, І. О. Снігурська

    The article provides a review of the literature on the problem of arterial hypertension (AH) in military personnel and veterans of various wars. It has been shown that this hypertension can be considered as one of the variants of stress‑induced hypertension (SIH) and is one of the most common cardiovascular diseases among these population groups. It is this form of AН that acquires special importance in Ukraine, taking into account the war that was unleashed by the Russian Federation. SIH is characterized by the increased blood pressure, primarily under the influence of psycho‑emotional factors. One of the important factors causing the body’s increased reaction to stress are genetic factors, first of all, burdened heredity for hypertension.The initial and key pathogenetic mechanism of the development and progression of hypertension under the influence of psycho‑emotional stress is activation of the sympathoadrenal system. Important and prognostically unfavorable features of hypertension in military personnel and war veterans include: frequent development at a young age, resistance to antihypertensive therapy, rapid progression with the development of hypertensive crises, damage to target organs, the development of atherosclerotic damage to various vascular beds, coronary heart disease, heart rhythm disorders and stroke.One of the early pathological changes that occur under the influence of stress are adaptation disorders of various degrees of intensity. Post‑traumatic stress disorder is singled out, which is the most severe and long‑lasting post‑stress disorder and at the same time a powerful factor in the development and progression of hypertension and its complications.The analyzed literature data indicate that AH in military personnel and war veterans is a major and far from solved medical and social problem. It is necessary to conduct a comprehensive and in‑depth examination of these categories of patients in order to develop the most effective approaches to their treatment and prevention of complications.


  • Open Access

    Possibilities of achieving target levels of arterial pressure and atherogenic lipids in patients with arterial hypertension with obesity at the outpatient stage (results of a 12-week follow-up)

    by С. М. Коваль, I. O. Snihurska, O. V. Mysnychenko, М. Ю. Пенькова, І. О. Снігурська

    The aim: To study the possibility of achieving target levels of blood pressure (BP) and atherogenic lipids’ levels in patients with arterial hypertension with abdominal obesity (AO) using combined antihypertensive and lipid‑lowering therapy against the background of recommendations for lifestyle correction at the outpatient stage. Materials and methods. The study involved 54 patients with AH of 2 and 3 degrees with AO of I — II degrees, who were examined in the polyclinic of the GI «L. T. Malaya Therapy National Institute of the NAMS of Ukraine». The investigated group included 30 (56 %) men and 24 (44 %) women, aged 47 to 59 years (the mean age — (50.6 ± 5.2) years). All patients underwent general clinical laboratory and instrumental examinations. After the initial examination, all patients were prescribed a three‑component fixed combination (FC) of antihypertensive drugs: an angiotensin‑converting enzyme inhibitor (ACE inhibitor) perindopril, a thiazide‑like diuretic (TPD) indapamide and a long‑acting dihydropyridine calcium channel blocker (CCB) amlodipine in optimal daily doses, considering blood pressure levels. Atorvastatin was administered as a lipid‑lowering drug in a daily dose, defined depending on the initial blood levels of low‑density lipoprotein cholesterol (LDL cholesterol). Achievement of the target levels of blood pressure and LDL‑cholesterol was assessed after 6 and 12 weeks of the study. Doses of antihypertensive drugs and atorvastatin were adjusted during the study. Results. It has been established that 6 weeks of treatment of AH patients with AO in outpatient settings with the use of three‑component fixed combination of antihypertensive drugs (ACE inhibitors, TPD and CCBs of the dihydropyridine series) and statins’ lipid‑lowering therapy against the background of recommendations for lifestyle correction, resulted in the achievement of the target “office” BP levels of in only 57 % of patients and target levels of LDL‑cholesterol in only 32 %. Insufficient efficacy of antihypertensive therapy in the examined patients was associated with a greater severity of obesity, increased heart rate (HR) and a higher incidence of left ventricular hypertrophy (LVH), while the low efficacy of statin therapy was primarily associated with the low therapy compliance. The addition of nebivolol, cardioselective beta‑adrenoblocker (BAB) with a vasodilatory effect, to the fixed combination of ACE inhibitors, TPD and BCC significantly increased the effectiveness of antihypertensive therapy. At the same time, intensification of statin therapy did not result in the significant increase of the frequency of achieving target levels of LDL cholesterol in the blood. Conclusions. The standard three‑component fixed combination of antihypertensive drugs in combination with medium‑dose statin therapy and recommendations for the normalization of lifestyle was not enough effective in a significant part of AH patients with AO at the outpatient stage, which indicates the need for timely correction of drug therapy and implementation of healthy lifestyle.

  • Open Access

    EFFECTIVENESS OF ADDITION OF METFORMIN TO STATIN THERAPY FOR PRODIABETOGENIC CHANGES CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY

    by Sergiy Koval, Olga Mysnychenko, Maryna Penkova, Olga Lytvynova, Oleksandr Berezin

    The aim: to study the effectiveness of adding metformin to statin therapy to correct prodiabetogenic changes in patients with arterial hypertension (AH) and abdominal obesity (AO). Materials and methods. We examined 65 patients with 2-3 degrees of AH in combination with AO of I-II degrees, atherogenic dyslipidemia and insulin resistance (IR) aged 47-59 yrs: group 1 – 35 patients who were treated with statins (atorvastatin) against the background of standard combinations of antihypertensive drugs, metformin was added; group 2 – 30 patients who did not receive metformin. The examination included generally accepted methods. Statistical data analysis was carried out using standard methods using Microsoft Excel 7.0 and SPSS 19.0 application packages. Results. The addition of metformin to atorvastatin against the background of standard antihypertensive therapy and recommendations for the normalization of lifestyle allowed a significant reduction in IR and the incidence of prediabetes in hypertensive patients with AO after 16 weeks of treatment. In patients who did not receive metformin, there was no decrease in these indicators. In the group of patients who used metformin, a significantly higher frequency of achieving target blood pressure levels was revealed than in the group of patients in whom this drug was not used. Conclusions. The effectiveness of the use of the insulin sensitizer metformin for the correction of pro-diabetogenic changes associated with statin therapy in patients with AH, which occurs against the background of AO, atherogenic dyslipidemia, and IR, has been shown.